Restoring tissue regeneration in patients with visceral Graft versus Host Disease.

Livrables

Consortium Sharepoint site and website on line

Report on identification of regulatory hurdles.

Report on identification of regulatory hurdles in setting up a multicentre Europewide study with ATMP

Publications

Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model

Auteurs: Frederick W. Thielen, Hedwig M. Blommestein, Liesbeth E.M. Oosten, Friso G. Calkoen, Arjan C. Lankester, Jaap J. Zwaginga, Katarina Le Blanc, Alba Redondo, Fermin Sánchez-Guijo, Mattia Algeri, Franco Locatelli, Wim E. Fibbe, Carin A. Uyl-de Groot
Publié dans: European Journal of Haematology, Numéro 101/5, 2018, Page(s) 676-683, ISSN 0902-4441
Éditeur: Blackwell Publishing Inc.
DOI: 10.1111/ejh.13158

Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization

Auteurs: Koen Schepers, Willem E. Fibbe
Publié dans: Annals of the New York Academy of Sciences, Numéro 1370/1, 2016, Page(s) 15-23, ISSN 0077-8923
Éditeur: New York Academy of Sciences
DOI: 10.1111/nyas.12984

Livrables

Publications

Partager cette page

Télécharger